New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 28, 2013
11:49 EDTMNST, QCOR, MRVLOptions with decreasing implied volatility: MNST DNDN DDD QCOR MRVL
News For MRVL;QCOR;MNST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2016
10:00 EDTMRVLOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Amedisys (AMED) upgraded to Outperform from Perform at Oppenheimer... American Campus (ACC) upgraded to Buy at Canaccord... Beacon Roofing (BECN) upgraded to Strong Buy from Outperform at Raymond James... Big 5 Sporting (BGFV) upgraded on potential Sports Authority closures at Stifel... CenterState Banks (CSFL) upgraded to Outperform from Market Perform at Fig Partners... Cisco (CSCO) upgraded to Neutral from Underperform at Macquarie... Dollar Tree (DLTR) upgraded to Outperform from Market Perform at Telsey Advisory... Dow Chemical (DOW) upgraded to Positive from Neutral at Susquehanna... Essex Property Trust (ESS) upgraded to Buy from Neutral at Mizuho... Globant (GLOB) upgraded to Buy from Neutral at Citi... Kinross Gold (KGC) upgraded on valuation, higher gold price at BMO Capital... L Brands (LB) upgraded to Buy from Hold at Brean Capital... Marvell (MRVL) upgraded to Buy from Sell at B. Riley... Munich Re (MURGY) upgraded to Neutral from Underperform at Credit Suisse... OM Asset Management (OMAM) upgraded to Buy from Neutral at Citi... Orbital ATK (OA) upgraded to Overweight from Sector Weight at KeyBanc... SCANA (SCG) upgraded to Buy from Neutral at Mizuho... Sensient (SXT) upgraded to Buy from Hold at Gabelli... St. Jude Medical (STJ) upgraded to Hold from Sell at Canaccord... Suffolk Bancorp (SCNB) upgraded to Outperform from Market Perform at Fig Partners... Supernus (SUPN) upgraded to Buy from Hold at Jefferies... Ultimate Software (ULTI) upgraded to Outperform from Market Perform at FBR Capital... ZAGG (ZAGG) upgraded to Outperform from Market Perform at Northland... athenahealth (ATHN) upgraded to Buy from Hold at Topeka.
06:32 EDTMRVLMarvell upgraded to Buy from Sell at B. Riley
Subscribe for More Information
February 3, 2016
15:13 EDTMRVLMarvell says will review any suggestions Starboard makes
Subscribe for More Information
11:33 EDTMRVLCiti slashes PC outlook, expresses caution on related stocks
Citi significantly lowered its 2016 PC sales estimates, citing recent negative data points. In conjunction with the call, the firm lowered its estimates for three companies whose results are significantly affected by PC sales: HP Inc. (HPQ), Marvell (MRVL) and Intersil (ISIL). WHAT'S NEW: Citi analyst Jim Silva now expects PC sales to drop 6% this year, down from his previous estimate of a 2% decline. Recent data points indicate that demand for PCs has dropped significantly so far this year, while inventories are above normal, the analyst explained. Constrained budgets and macro concerns are restraining demand for PCs, Silva believes. Meanwhile, "there is not enough evidence" to conclude that the launch of Microsoft's (MSFT) Windows 10 will be a positive catalyst for PC sales this year, Silva said. Citing his view of PC trends, along with increased competition in the printer space, Silva lowered his 2016 EPS estimate for HP to $1.53 from $1.64. Statements by other printer makers, including Xerox (XRX) and Canon (CAJ), suggest that HP's margins on printers will "come under additional pressure," the analyst believes. He lowered his price target on the name to $10.75 from $14.50 and expects the stock to remain range-bound until analysts reduce their estimates further or its end markets improve. Intersil has 20% exposure to the PC market and the sales of its products related to computing are still strongly correlated with PC sales, Citi analyst Atif Malik stated. As a result, the company will face revenue headwinds throughout this year, stated the analyst. Malik, who expects the company's 2016 and 2017 EPS to come in below consensus levels, downgraded the stock to Sell from Neutral and set an $11.50 price target on the shares. Estimating Marvell's PC exposure at about 60%, Malik lowered his 2016 EPS estimate for the company to 42c from 48c and kept a Sell rating on the name. WHAT'S NOTABLE: Hedge fund Starboard Value disclosed this morning that it had bought a 6.7% activist stake in Marvell. The hedge fund said the shares are "undervalued" and The Wall Street Journal, citing sources familiar with the situation, said Starboard is betting the company can its boost margins by cutting costs, perhaps exiting its mobile device business. PRICE ACTION: In late morning trading, HP Inc. fell 3.3% to $9.55, Marvell rose 1.25% to $8.78 and Intersil dropped 4.4% to $11.93.
09:19 EDTMRVLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Boot Barn (BOOT), up 20.7%... Oclaro (OCLR), up 8.2%... Edwards Lifesciences (EW), up 5.8%... Natural Health (NHTC), up 5.7%... Viavi Solutions (VIAV), up 2.8%. ALSO HIGHER: Conatus (CNAT), up 18.8% after the FDA has granted Fast Track designation to the company's emricasan development program for the treatment of liver cirrhosis... Marvell Technology (MRVL), up 3.3% after Starboard Value disclosed a 6.7% activist stake in the company... Syngenta (SYT), up 2.9% after ChemChina offers to acquire the company in a transaction valued over $43B. DOWN AFTER EARNINGS: Navios Maritime Partners (NMM), down 33.5%... National-Oilwell Varco (NOV), down 7.9%... Chipotle (CMG), down 5.7%... Yahoo (YHOO), down 1.9%... Mondelez (MDLZ), down 4.4%... Illumina (ILMN), down 4.6%... Alexion Pharmaceuticals (ALXN), down 3.5%... Merck (MRK), down fractionally.
06:50 EDTMRVLIntersil downgraded to Sell from Neutral at Citi
Subscribe for More Information
06:20 EDTMRVLStarboard reports activist stake in Marvell Technology
Jeffrey Smith's Starboard Value disclosed this morning a 6.7% activist stake in Marvell Technology Group. Starboard bought the position on the belief that the shares, when purchased, were "undervalued and represented an attractive investment opportunity." The hedge fund said it retained Rick Hill, Oleg Khaykin and Jeff McCreary as advisors in connection with its investment given their "unique skill set, industry experience and industry knowledge." The Wall Street Journal last night reported Starboard would take an activist stake in chipmaker as it sees opportunity for cost cuts.
05:56 EDTMRVLStarboard expected to report 6.7% stake in Marvell, WSJ reports
Starboard Value, an activist investor, is expected to report today that it has taken a 6.7% stake in Marvell Technology, a semiconductor company currently facing investigations into its accounting, The Wall Street Journal says, citing sources familiar with the situation. According to the sources, Starboard is betting the company can its boost margins by cutting costs, perhaps exiting its mobile device business. Reference Link
February 1, 2016
11:18 EDTMNSTWells Fargo, Citron take sides in Monster Beverage debate
Monster Beverage (MNST) is rising slightly in the down market after Wells Fargo upgraded the stock, saying that the shares have reached a compelling entry point while Monster's convenience store sales appear to have accelerated. UPGRADE: The recent weakness in Monster's stock has created a "compelling entry point," according to Wells Fargo analyst Bonnie Herzog, who upgraded the stock to Outperform from Market Perform. Moreover, Wells Fargo's survey of beverage retailers suggests that the company's sales at convenience stores rose 10% last quarter, up from 7% in Q3. Additionally, the survey found that the quality of Monster's distribution operation had greatly improved in recent months. As a result, Herzog wrote that the issues caused by the company's transition to using Coca-Cola's (KO) distribution system had been "largely resolved." Monster's earnings growth should accelerate over the next five years as it penetrates new overseas markets, including China, the analyst contended. There are "numerous scenarios" that would enable the beverage maker to beat earnings expectations going forward, Herzog believes. In addition to international expansion, the company could benefit from accelerated share buybacks, a reduced tax rate and "major innovations" in beverages outside of its core energy business, according to Herzog. She raised her price target on the shares to $159-$161 from $139-$141. SHORT REPORT: On January 29, short-selling research firm Citron wrote that Monster's "valuation..is completely removed from reality." Over the past five years, Monster's stock has surged 500%, even though its revenue has only increased 90%, the firm stated. Meanwhile, Coca-Cola's 2014 purchase of a stake in Monster will prevent the latter company from being acquired, as Coke is not interested in buying Monster, Citron contended. In China, Monster will have to cope with high start-up costs, tough competition and lower margins, Citron warned. Furthermore, the company's new products cannibalize its existing drinks, Citron believes. Also on January 29, the small Eastern European country of Latvia decided to ban sales of energy drinks to minors. PRICE ACTION: In late morning trading, Monster climbed 2% to $137.73. The stock dipped about 1.6% on Friday.
10:00 EDTMNSTOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Air Products (APD) upgraded to Buy from Neutral at UBS... American Airlines (AAL) upgraded to Outperform from Market Perform at Cowen... Axiall (AXLL) upgraded to Overweight from Neutral at JPMorgan... BASF (BASFY) upgraded to Buy from Hold at Societe Generale... CNH Industrial (CNHI) upgraded to Neutral from Underperform at BofA/Merrill... CU Bancorp (CUNB) upgraded to Outperform from Market Perform at Fig Partners... CaixaBank (CAIXY) upgraded to Hold from Sell at Societe Generale... Chipotle (CMG) upgraded to Neutral from Underperform at BofA/Merrill... Concho Resources (CXO) upgraded to Buy from Neutral at SunTrust... Continental Building (CBPX) upgraded to Buy from Hold at BB&T... Eastman Chemical (EMN) upgraded to Buy from Outperform at CLSA... Extreme Networks (EXTR) upgraded to Buy from Hold at Needham... Glacier Bancorp (GBCI) upgraded to Outperform from Market Perform at Fig Partners... IBERIABANK (IBKC) upgraded to Strong Buy from Outperform at Raymond James... Infineon (IFNNY) upgraded to Buy from Neutral at UBS... Jarden (JAH) upgraded to Outperform from Market Perform at Raymond James... Joy Global (JOY) upgraded to Overweight from Equal Weight at Barclays... KT Corporation (KT) upgraded to Overweight from Neutral at JPMorgan... Kennametal (KMT) upgraded to Neutral from Underperform at BofA/Merrill... L-3 Communications (LLL) upgraded to Buy on valuation at BofA/Merrill... Maximus (MMS) upgraded to Outperform from Market Perform at Raymond James... Micron (MU) upgraded to Neutral from Sell at Goldman... Monster Beverage (MNST) upgraded to Outperform from Market Perform at Wells Fargo... Newell Rubbermaid (NWL) upgraded to Outperform from Market Perform at Raymond James... Northrop Grumman (NOC) upgraded to Buy from Neutral at BofA/Merrill... PTC (PTC) upgraded to Buy from Neutral at Sterne Agee CRT... Peoples Bancorp (PEBO) upgraded to Outperform from Neutral at Boenning & Scattergood... Praxair (PX) upgraded to Buy from Neutral at UBS... Proofpoint (PFPT) upgraded to Outperform from In-Line at Imperial Capital... Seagate (STX) upgraded to Hold from Sell at Benchmark... Siemens (SIEGY) upgraded to Buy from Neutral at Nomura... Superior Drilling (SDPI) upgraded to Buy from Hold at Wunderlich... Vertex (VRTX) upgraded to Buy from Hold at Jefferies... Werner (WERN) upgraded to Strong Buy from Outperform at Raymond James... ZAIS Financial (ZFC) upgraded to Overweight from Equal Weight at Barclays.
06:14 EDTMNSTMonster Beverage upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Bonnie Herzog upgraded Monster Beverage to Outperform saying the recent pullback in the shares provides a "compelling" entry point. The analyst points out her firm's recent beverage survey indicates Monster's U.S. distribution issues have largely been resolved and that the company's earnings are poised to reaccelerate in 2016 and beyond. Herzog raised her price target for Monster shares to $159-$161 from $139-$141. The energy drink maker closed Friday down $2.17 to $135.03 after Citron Research posted a cautious report on the company.
January 29, 2016
12:50 EDTMNSTOptions with increasing put volume
Options with increasing put volume: MNST STLD LC LPX DRII MEOH STMP VMW XRX XLP
12:45 EDTMNSTMonster Beverage puts active on Citron sees shares hitting $80 in near term
Subscribe for More Information
12:24 EDTMNSTCitron sees Monster Beverage shares hitting $80 in near term
Shares of Monster Beverage (MNST) are likely to hit $80 in the near term, Citron Research writes in a new research report on the energy drink maker. The short-selling research firm says valuing Monster versus Dr Pepper Snapple (DPS) results in 48% downside for the stock. "For the sake of the benefit of the doubt we used the post GMCR takeout value as a benchmark to get to $80 a share for Monster," Citron states. Monster shares are down $7.15, or 5%, to $130.05 in midday trading. Reference Link
12:18 EDTMNSTCitron puts $80 price target on Monster Beverage
Subscribe for More Information
11:14 EDTMNSTLatvia to ban energy drink sales to minors, Nutra Ingredients reports
Subscribe for More Information
11:12 EDTMNSTMonster Beverage weakness an overrreaction, says Stifel
Stifel said Monster is underperforming on concerns that a ban on energy drink sales to those under 18 years of age in Latvia could spread to other countries. Stifel said the concerns are a considerable overreaction, creating a buying opportunity. The firm's analyst said Latvia is barely a rounding error of the global energy drink market, and likely less than 0.1% of Monster's sales.
10:16 EDTMNSTOptions with increasing implied volatility: WMB W CERS RAD CRM GILD MNST
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use